GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Pharmaniaga Bhd (XKLS:7081) » Definitions » Gross Margin %

Pharmaniaga Bhd (XKLS:7081) Gross Margin % : 12.78% (As of Mar. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Pharmaniaga Bhd Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Pharmaniaga Bhd's Gross Profit for the three months ended in Mar. 2024 was RM123 Mil. Pharmaniaga Bhd's Revenue for the three months ended in Mar. 2024 was RM965 Mil. Therefore, Pharmaniaga Bhd's Gross Margin % for the quarter that ended in Mar. 2024 was 12.78%.


The historical rank and industry rank for Pharmaniaga Bhd's Gross Margin % or its related term are showing as below:

XKLS:7081' s Gross Margin % Range Over the Past 10 Years
Min: -6.02   Med: 13.3   Max: 16.46
Current: 9.66


During the past 13 years, the highest Gross Margin % of Pharmaniaga Bhd was 16.46%. The lowest was -6.02%. And the median was 13.30%.

XKLS:7081's Gross Margin % is ranked worse than
72.63% of 95 companies
in the Medical Distribution industry
Industry Median: 16.27 vs XKLS:7081: 9.66

Pharmaniaga Bhd had a gross margin of 12.78% for the quarter that ended in Mar. 2024 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Pharmaniaga Bhd was 0.00% per year.


Pharmaniaga Bhd Gross Margin % Historical Data

The historical data trend for Pharmaniaga Bhd's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaniaga Bhd Gross Margin % Chart

Pharmaniaga Bhd Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.33 10.83 13.08 -6.02 9.04

Pharmaniaga Bhd Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.70 11.43 12.45 0.81 12.78

Competitive Comparison of Pharmaniaga Bhd's Gross Margin %

For the Medical Distribution subindustry, Pharmaniaga Bhd's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmaniaga Bhd's Gross Margin % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Pharmaniaga Bhd's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Pharmaniaga Bhd's Gross Margin % falls into.



Pharmaniaga Bhd Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Pharmaniaga Bhd's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=307.8 / 3404.481
=(Revenue - Cost of Goods Sold) / Revenue
=(3404.481 - 3096.66) / 3404.481
=9.04 %

Pharmaniaga Bhd's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=123.3 / 964.959
=(Revenue - Cost of Goods Sold) / Revenue
=(964.959 - 841.65) / 964.959
=12.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Pharmaniaga Bhd  (XKLS:7081) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Pharmaniaga Bhd had a gross margin of 12.78% for the quarter that ended in Mar. 2024 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Pharmaniaga Bhd Gross Margin % Related Terms

Thank you for viewing the detailed overview of Pharmaniaga Bhd's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmaniaga Bhd (XKLS:7081) Business Description

Traded in Other Exchanges
N/A
Address
No. 7, Lorong Keluli 1B, Kawasan Perindustrian Bukit Raja Selatan, Seksyen 7, Shah Alam, SGR, MYS, 40000
Pharmaniaga Bhd is engaged in the manufacture of pharmaceuticals and medical devices, sales and marketing as well as the distribution of medical products and hospital equipment. The company is also involved in logistics and distribution. The group operates in three segments - Logistics and distribution, Manufacturing, and Indonesia. Maximum revenue is generated by the logistics and distribution segment. It derives revenue from Malaysia, Indonesia and Other countries, of which key revenue is derived from Malaysia.

Pharmaniaga Bhd (XKLS:7081) Headlines

No Headlines